ELANCO ANIMAL HEALTH INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.78 USD | -1.26% |
|
-1.76% | +12.55% |
Presenter SpeechTiffany Kanaga (Executives)Welcome to the Elanco Animal Health 2020 Investor D...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, poultry, and aquaculture. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Sector
Pharmaceuticals
Calendar
30/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
17
USD
Average target price
19.11
USD
Spread / Average Target
+12.44%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.55% | 8.4B | |
| -12.20% | 79.57B | |
| +25.88% | 3.76B | |
| -0.14% | 3.18B | |
| +14.19% | 1.67B | |
| +0.56% | 1.64B | |
| -17.79% | 1.38B | |
| -0.39% | 1.32B | |
| -5.20% | 1.24B | |
| +6.40% | 1.12B |
- Stock Market
- Equities
- ELAN Stock
- News Elanco Animal Health Incorporated
- Transcript : Elanco Animal Health Incorporated - Analyst/Investor Day
